Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75.

Article  PubMed  PubMed Central  Google Scholar 

Inadomi J, Alastal H, Bonavina L, et al. Recent advances in Barrett’s esophagus. Ann N Y Acad Sci. 2018;1434:227–38.

Article  PubMed  Google Scholar 

Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;14:5598–606.

Article  Google Scholar 

Huang FL, Yu SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210–5.

Article  PubMed  Google Scholar 

Abrams JA, Fields S, Lightdale CJ, et al. Racial and ethnic disparities in the prevalence of Barrett’s esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol. 2008;6:30–4.

Article  PubMed  Google Scholar 

Drahos J, Ricker W, Parsons R, et al. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data. J Clin Gastroenterol. 2015;49:282–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drahos J, Ricker W, Pfeiffer RM, et al. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: an analysis of SEER-Medicare data. Cancer. 2017;123:657–65.

Article  PubMed  Google Scholar 

Engels EA, Pfeiffer RM, Ricker W, et al. Use of Surveillance, Epidemiology, and end results-Medicare Data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol. 2011;174:860–70.

Article  PubMed  PubMed Central  Google Scholar 

Stocks T, Bjørge T, Ulmer H, et al. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol. 2015;44:1353–63.

Article  PubMed  PubMed Central  Google Scholar 

Thrift AP, Shaheen NJ, Gammon MD, et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a mendelian randomization study. J Natl Cancer Inst. 2014;106:dju252.

Article  PubMed  PubMed Central  Google Scholar 

Xu B, Zhou X, Li X, et al. Diabetes mellitus carries a risk of esophageal cancer: a meta-analysis. Med (Baltim). 2017;96:e7944.

Article  Google Scholar 

Iyer PG, Borah BJ, Heien HC, et al. Association of Barrett’s esophagus with type II diabetes Mellitus: results from a large population-based case-control study. Clin Gastroenterol Hepatol. 2013;11:1108–14.

Article  PubMed  Google Scholar 

Wang J, Zhuge J, Feng D, et al. Mendelian randomization study of circulating lipids and biliary tract cancer among East asians. BMC Cancer. 2022;22:273.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowak C, Ärnlöv J. A mendelian randomization study of the effects of blood lipids on breast cancer risk. Nat Commun. 2018;9:3957.

Article  PubMed  PubMed Central  Google Scholar 

Sako A, Kitayama J, Kaisaki S, et al. Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma. Cancer Lett. 2004;208:43–9.

Article  CAS  PubMed  Google Scholar 

Xie SH, Rabbani S, Ness-Jensen E, et al. Circulating levels of inflammatory and metabolic biomarkers and risk of esophageal adenocarcinoma and Barrett Esophagus: systematic review and Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2020;29:2109–18.

Article  CAS  PubMed  Google Scholar 

Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925–6.

Article  PubMed  Google Scholar 

Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klimentidis YC, Arora A, Newell M, et al. Phenotypic and Genetic Characterization of Lower LDL Cholesterol and increased type 2 diabetes risk in the UK Biobank. Diabetes. 2020;69:2194–205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ong JS, An J, Han X, et al. Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. Gut. 2022;71:1053–61.

Article  PubMed  Google Scholar 

Eusebi LH, Cirota GG, Zagari RM, et al. Global prevalence of Barrett’s oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Gut. 2021;70(3):456–63.

Article  CAS  PubMed  Google Scholar 

Burgess S, Thompson SG. Multivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181:251–60.

Cao H, Baranova A, Wei X et al. Bidirectional causal associations between type 2 diabetes and COVID-19. J Med Virol. 2022.

Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.

Article  PubMed  PubMed Central  Google Scholar 

Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowden J, Del Greco MF, Minelli C, et al. Improving the accuracy of two-sample summary-data mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48:728–42.

Article  PubMed  Google Scholar 

Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21:223–42.

Article  PubMed  PubMed Central  Google Scholar 

Shim H, Chasman DI, Smith JD, et al. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 caucasians. PLoS ONE. 2015;10:e0120758.

Article  PubMed  PubMed Central  Google Scholar 

Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in mendelian randomization studies. Int J Epidemiol. 2013;42:1497–501.

Article  PubMed  Google Scholar 

Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr. 2001;20:97–105.

Article  CAS  PubMed  Google Scholar 

Huang MC, Graeler M, Shankar G, et al. Lysophospholipid mediators of immunity and neoplasia. Biochim Biophys Acta. 2002;1582:161–7.

Article  CAS  PubMed  Google Scholar 

Liu S, Jiang H, Min L, et al. Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression. Carcinogenesis. 2021;42:611–20.

Article  CAS  PubMed  Google Scholar 

Baranova A, Song Y, Cao H, et al. Causal associations between basal metabolic rate and COVID-19. Diabetes. 2023;72:149–54.

Article  CAS  PubMed  Google Scholar